Your browser doesn't support javascript.
loading
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.
Kotajima-Murakami, Hiroko; Takano, Ayumi; Hirakawa, Shinya; Ogai, Yasukazu; Funada, Daisuke; Tanibuchi, Yuko; Ban, Eriko; Kikuchi, Minako; Tachimori, Hisateru; Maruo, Kazushi; Kawashima, Takahiro; Tomo, Yui; Sasaki, Tsuyoshi; Oi, Hideki; Matsumoto, Toshihiko; Ikeda, Kazutaka.
Afiliación
  • Kotajima-Murakami H; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Takano A; Department of Drug Dependence Research, National Institute of Mental Health, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Hirakawa S; Department of Drug Dependence Research, National Institute of Mental Health, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Ogai Y; Department of Mental Health and Psychiatric Nursing, Tokyo Medical and Dental University, Tokyo, Japan.
  • Funada D; Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Tanibuchi Y; Social Psychiatry and Mental Health, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Ban E; Department of Psychiatry, National Centre Hospital, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Kikuchi M; Department of Drug Dependence Research, National Institute of Mental Health, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Tachimori H; Department of Psychiatry, Chiba Hospital, Chiba, Japan.
  • Maruo K; Department of Drug Dependence Research, National Institute of Mental Health, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Kawashima T; Department of Drug Dependence Research, National Institute of Mental Health, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Tomo Y; Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Sasaki T; Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Oi H; Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Matsumoto T; Department of Clinical Data Science, Clinical Research & Education Promotion Division, National Centre of Neurology and Psychiatry, Tokyo, Japan.
  • Ikeda K; Department of Child Psychiatry, Chiba-University Hospital, Chiba, Japan.
Neuropsychopharmacol Rep ; 42(1): 92-104, 2022 03.
Article en En | MEDLINE | ID: mdl-35068087
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estimulantes del Sistema Nervioso Central / Metanfetamina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Neuropsychopharmacol Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estimulantes del Sistema Nervioso Central / Metanfetamina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Neuropsychopharmacol Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón